Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | ADAMTS5 | Q9UNA0 | 12/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30876612 | 0.90 | ADAMTS5 (0.49) | HTTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL24634710 | 0.89 | KDM4E (0.54) | HTTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL30876648 | 0.89 | KDM4E (0.54) | HTTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL27196432 | 0.86 | ALOX12 (0.66) | HTTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL29856067 | 0.85 | HTT (0.56) | HTTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL30876636 | 0.84 | KDM4E (0.56) | HTTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL24634704 | 0.84 | KDM4E (0.56) | HTTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL29856065 | 0.80 | ADAMTS5 (0.52) | HTTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL30876644 | 0.79 | HTT (0.53) | HTTSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL24634713 | 0.79 | HTT (0.53) | HTTSMN1; SMN2MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240124419-A1 | SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124419-A1 | SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF | HSPA5, HSPA2, PSMG3 | HTT 2113/4885SMN1; SMN2 2825/4885MEN1 4673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.